ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 70 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50,261 | -43.9% | 64,437 | -33.5% | 0.00% | – |
Q2 2023 | $89,667 | +142.0% | 96,937 | +185.1% | 0.00% | – |
Q1 2023 | $37,060 | -16.2% | 34,000 | +12.2% | 0.00% | – |
Q4 2022 | $44,238 | +34.1% | 30,300 | -2.6% | 0.00% | – |
Q3 2022 | $33,000 | -45.0% | 31,100 | -11.9% | 0.00% | – |
Q2 2022 | $60,000 | -72.2% | 35,300 | -66.4% | 0.00% | -100.0% |
Q1 2022 | $216,000 | – | 105,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,054,864 | $8,597,000 | 5.88% |
NEA Management Company, LLC | 9,880,999 | $80,530,000 | 4.18% |
Abingworth LLP | 250,000 | $2,033,000 | 2.13% |
New Leaf Venture Partners, L.L.C. | 127,041 | $1,035,000 | 0.89% |
Iguana Healthcare Management, LLC | 200,000 | $1,630,000 | 0.66% |
Rock Springs Capital Management LP | 765,001 | $6,235,000 | 0.46% |
QVT Financial LP | 783,645 | $6,387,000 | 0.44% |
Opaleye Management Inc. | 40,000 | $326,000 | 0.22% |
Rathbones Group PLC | 450,525 | $3,672,000 | 0.20% |
Virtus ETF Advisers LLC | 26,974 | $220,000 | 0.16% |